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Abstract
Summary Childhood body mass index (BMI) gain is linked
to hip fracture risk in elderly. In healthy girls, menarcheal
age is inversely related to BMI gain during childhood and
to femoral neck areal bone mass density (aBMD) and distal
tibia structural components at maturity. This study under-
scores the importance of pubertal timing in age-related
fragility fracture risk.
Introduction Recent data point to a relationship between
BMI change during childhood and hip fracture risk in later
life. We hypothesized that BMI development is linked to
variation in pubertal timing as assessed by menarcheal age
(MENA) which in turn, is related to peak bone mass (PBM)
and hip fracture risk in elderly.
Methods We studied in a 124 healthy female cohort the
relationship between MENA and BMI from birth to maturity,
and DXA-measured femoral neck (FN) aBMD at 20.4 year.
At this age, we also measured bone strength related
microstructure components of distal tibia by HR-pQCT.
Results At 20.4±0.6 year, FN aBMD (mg/cm2), cortical
thickness (μm), and trabecular density (mg HA/cm3) of
distal tibia were inversely related to MENA (P=0.023,
0.015, and 0.041, respectively) and positively to BMI
changes from 1.0 to 12.4 years (P=0.031, 0.089, 0.016,
respectively). Significant inverse (P<0.022 to <0.001)
correlations (R=−0.21 to –0.42) were found between
MENA and BMI from 7.9 to 20.4 years, but neither at
birth nor at 1.0 year. Linear regression indicated that
MENA Z-score was inversely related to BMI changes not
only from 1.0 to 12.4 years (R=−0.35, P=0.001), but also
from 1.0 to 8.9 years, (R=−0.24, P=0.017), i.e., before
pubertal maturation.
Conclusion BMI gain during childhood is associated with
pubertal timing, which in turn, is correlated with several
bone traits measured at PBM including FN aBMD, cortical
thickness, and volumetric trabecular density of distal tibia.
These data complement the reported relationship between
childhood BMI gain and hip fracture risk in later life.
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Introduction
In healthy human subjects, bone mineral mass follows a
trajectory from birth on to attain a maximal value, the so-
called peak bone mass (PBM), by the end of the second or
the beginning of the third decade, according to both gender
and skeletal sites examined [1].
Later menarcheal age was shown to be a risk factor for
reduced bone mineral mass in postmenopausal women [2–7]
and increased prevalence of fragility fractures at several sites
of the skeleton [8–11].
The negative influence of later menarcheal age on bone
mineral mass observed in postmenopausal women is
already expressed long before menopause as it was
observed in middle-age premenopausal women with mean
age 45 years, and in healthy young adult females in their
very early twenties [12]. Furthermore, this influence of
pubertal timing on peak bone mass was found to be
predetermined before the onset of pubertal maturation in a
prospective follow-up study from age 8 to 20 years [13].
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This suggested that both pubertal timing and bone traits
may be under the influence of common genetic factors [14].
The risk of hip fracture is dependent upon the amount of
areal bone mineral density (aBMD) or bone mineral content
(BMC) as assessed by osteodensitometry at the level of
proximal femur, particularly in the femoral neck (FN).
Longitudinal studies of women ranging from 20 to 94 years
with follow-up periods from 16 to 22 years showed that the
average annual rate of bone loss was relatively constant and
tracked well within individuals [15, 16]. Furthermore, a high
correlation was recorded between the baseline aBMD values
and those obtained after 16 (R=0.83) [15] and 22 (R=0.80)
years of follow-up [16]. This tracking pattern of aBMD is
thus maintained over six decades of adult life. Such a notion
has two important implications. First, the prediction of hip
fracture risk based on one single measurement of FN aBMD
remains reliable in the long term [15, 16]. Second, within the
wide range of FN aBMD values little variation occurs during
adult life in individual Z-scores or percentiles. Hence, it can
be inferred that bone mass acquired by the end of the growth
period appears to be more important than bone loss occurring
during adult life [17].
This tracking pattern of FN aBMD was also reported in
healthy females, from prepuberty to peak bone mass
attainment [18–20]. In fact, since PBM is under strong
genetic influence [21–23], it can be expected that bone
mineral density and size are found to significantly track
during growth in healthy populations throughout the world
[18, 20, 24–26].
Growth in infancy was reported to be associated with
BMC in later life [27]. The risk of hip fracture in elderly
was shown to be related to early variation in height and
weight growth [28, 29]. Very recently, in a study of 6,370
women born in Finland, reduction in body mass index
(BMI) gain between 1 and 12 years of age was associated
with an increase risk of hip fracture in later life [30]. Two
potential explanations for this link between reduction in Z-
score for BMI and later fracture risk are discussed by the
authors: first, a difference in pubertal timing; second, a
slowing of growth in response to adverse environmental
influences [30]. The authors concluded that thinness in
childhood is a risk factor for hip fracture in later life, by a
direct effect of low fat mass on bone mineralization or
represents the influence of altered timing of pubertal
maturation. In this study, the timing of puberty as precisely
assessed by prospectively recording menarcheal age, was
not determined [30], making uncertain whether this
important determinant of FN PBM and subsequent pre-
menopausal FN aBMD [12] could be implicated in this
association.
In the present report, we tested the hypothesis that
variation in body growth during infancy and childhood are
related to pubertal timing which, in turn is a determinant of
FN peak bone mass. Data are presented on the relationship
between menarcheal age and body weight (BW), height (H)
and BMI from birth to 20 years, and in FN aBMD
prospectively measured from prepuberty to maturity in a
cohort of healthy females. In addition to FN PBM
measurements, we also analyzed whether the impact of
BMI as linked to pubertal timing was detectable on bone
strength related microstructure, as assessed by high resolution
peripheral computerized tomography (HR-pQCT) at the level
of distal tibia.
Subjects and methods
Participants
We studied 124 healthy women with mean (±SD) age of
20.4±0.6 year. They belong to a cohort followed during
12 years and previously examined at mean age 7.9±0.5, 8.9±
0.5, 10.0±0.5 [31], 12.4±0.5 [32], and 16.4±0.5 year [33].
During 1 year, between mean age of 7.9 and 8.9 years, half
the cohort received a supplementation of calcium in a
randomized, double-blind, placebo-controlled design, as
previously reported [31]. Exclusion criteria at baseline were:
ratio of weight/height <3rd or >97th percentile, physical
signs of puberty, chronic disease, malabsorption, bone
disease, and regular use of medication as previously
described [31].
The ethics committees of the Department of Pediatrics and
the Department of Rehabilitation and Geriatrics of the
University Hospitals of Geneva approved the protocol while
informed consent was obtained from both parents and children
[31]. All subjects were recruited within the Geneva area.
Clinical assessment
Body weight, standing height, and BMI (kg/m2) were
retrospectively obtained at birth (n=115) and 1 year of age
(n=96) through questionnaires sent to the parents and the
pediatricians. These anthropometric variables were then
prospectively measured at each visit from 7.9 years of age
on. At mean age (±SD) 7.9±0.5 and 8.9±0.5 year, pubertal
stage was assessed by direct clinical examination made by a
pediatrician–endocrinologist. At mean age of 10.0, 12.4,
and 16.4 years pubertal maturation was assessed by a self-
assessment questionnaire with drawings and written de-
scription of Tanner’s breast and pubic hair. At mean age 7.9
and 8.9 years, all girls were classified Tanner’s stage P1
while at mean age of 10.0 years, 38% of them had reached
Tanner’s stage P2. Menarcheal age (MENA) was then
assessed prospectively by direct interview at the second,
third, fourth, and fifth visits, i.e., at the mean age of 8.9,
10.0, 12.4, and 16.4 years. MENAwas within physiological
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range in all girls according to reference values established
in the general population living in the same area [33].
Moreover, there was no case of pathological delayed or
precocious puberty. The use of contraceptive pill for more
than 3 months was recorded as well as smoking expressed
in yearly pack units.
Calcium intake
At each visit from 7.9 years, spontaneous, i.e., baseline
calcium intake, as essentially assessed from dairy sources,
was estimated by a frequency questionnaire [34].
Measurement of bone variables
Areal bone mineral density (mg/cm2) was measured by
dual-energy X-ray absorptiometry (DXA) at the level of the
femoral neck (FN) with a Hologic QDR-4500 instrument
(Waltham, MA, USA), as previously reported [33]. The
coefficient of variation of repeated aBMD measurements
varied between 1.0% and 1.6% [33].Volumetric bone
density and microstructure were determined at the distal
tibia by HR-pQCT on an XtremeCT instrument (Scanco
medical AG®, Basserdorf, Switzerland), as previously
described [35]. At the distal tibia, 110 parallel CT slices
with a nominal resolution (voxel size) of 82 μm were
obtained, thus delivering a three-dimensional representation
of approximately 9 mm in the axial direction. An
anteroposterior scout view was used to define the measure-
ment region. Briefly, a reference line was manually placed
at the endplate of the tibia and the first CT slice was
22.5 mm distal to the reference line. The following
variables were measured: total (Dtot), cortical (Dcort), and
trabecular (Dtrab) volumetric bone density expressed as mg
hydroxyapatite (HA)/cm3; trabecular bone volume fraction
(BV/TV, %), trabecular number (Tb.N), thickness (Tb.Th,
μm) and spacing (Tb.Sp, μm); mean cortical thickness (Ct.
Th, μm) and cross-sectional area (CSA, mm2). The in vivo
short-term reproducibility of HR-pQCT at the distal tibia
assessed in 15 subjects with repositioning varied from 0.7%
to 1.0% and from 3.0% to 4.9% for bone density and for
trabecular architecture, respectively. These reproducibility
ranges in our facility are similar to those recently published
[36].
Expression of the results and statistical analysis
The various anthropometric and osteodensitometric varia-
bles are given as mean±SD. MENA and BMI as well as FN
aBMD or distal tibia Ct.Th and Dtrab were expressed in Z-
scores computed from this healthy female cohort. The mean
values of anthropometric variable gains were expressed
either in absolute terms or as the difference of the relative
(Z-score) values at the different ages. A multivariate model
adjusted for repeated measures using individual values of
age and BMI Z-score at each visit was performed to
demonstrate the overall significant association between
BMI Z-score and MENA Z-score (β=−0.256, P≤0.001,
R2=0.07). Since an improvement in the coefficient of
determination (R2) was observed when the model was
repeated without taking into account values at birth and
1 year of age, we looked at which age the relationship
between BMI Z-score and menarcheal age Z-score was
most significant. Then, univariate analysis at different time
points were performed between BMI Z-score and MENA
Z-score and between delta BMI Z-score and MENA Z-
score. The relationships between bone traits expressed in Z-
scores and MENA Z-score or delta BMI expressed in
absolute terms were also examined by univariate regression
analysis. The subjects were segregated according to the
median of menarcheal age. Timing of menarche (MENA)
under and above the median age of the first menstruation
was defined as “EARLIER” and “LATER,” respectively.
The differences in anthropometric characteristics between
EARLIER and LATER MENA were assessed by unpaired
Student’s t test or by Wilcoxon signed rank test according
to the variable distribution pattern. The significance level
for two-sided P values was 0.05 for all tests. The data were
analyzed using STATA software, version 9.0 (StataCorp LP,
College Station, TX, USA).
Results
The whole cohort anthropometric variables from birth on
and the development of DXA-measured FN aBMD from
prepuberty to early twenties are described in Table 1. All
values are within the reference ranges of the corresponding
population of healthy female subjects. Among the 124
young women, 64 (51.6%) were current (n=50) or previous
smokers (n=14). The use of contraceptive pill for more
than 3 months concerned 24 (19.4%) young women. There
was no significant difference between girls with (n=96) and
without (n=28) birth weight and infant weight in terms of
BMI, femoral neck aBMD and distal tibia pQCT values at
the mean age of 20.4 years. At birth and at 1.0 year of age,
there was no relationship between future menarcheal age,
taken as a precise assessment of pubertal timing, and BMI
(Table 2). In contrast, highly significant inverse regression
coefficients (ß) were recorded at the age of 7.9 and
8.9 years, i.e., when all girls were still prepubertal as
indicated in the legend in Table 1. The inverse regression
coefficient still became maximally negative at the age of
12.4 year (ß=−0.455, P<0.001). At this age, MENA
explained 18% of the BMI variance (R2=0.18) (Table 2).
Afterwards, the negative slope regression of BMI on
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MENA was less steep, but still remained statistically
significant at the beginning of the third decade (Table 2).
Regression coefficients were also calculated between
MENA and BMI gains (Table 2). No relationship was
found with BMI increment from birth to 1.0 year of age. In
contrast, the regression coefficient of BMI gain on MENA
was inversely related from 1.0 to 8.9 years, and 10.0 and
12.4 years. At this age, the negative slope of BMI gain on
MENA was the steepest (Table 2). The regression coeffi-
cient was no longer significantly less than zero at 16.4 and
20.4 years of age. Adjustment by smoking and contracep-
tive pill use did not modify the statistical significance of the
regressions calculated between BMI Z-score or gain in BMI
Z-score at 16.4 and 20 years of age and menarcheal age Z-
score (Table 2).
As shown in Fig. 1a, b and c, the slopes of the linear
regressions between FN aBMD, Ct.Th, and BV/TVof distal
tibia, measured at 20.4 years, and MENA are negative. It
ensues that the relationships between these three bone
variables and BMI gains from 1 to 12.4 years are positively
related (Fig. 1d, e, and f).
The relation between pubertal timing and both anthro-
pometric and bone variables was further analyzed by
segregating the cohort by the median (12.9 years) of
MENA. At birth and 1 year of age, no difference in BW,
H, and thereby in BMI was detected between girls who will
experience pubertal timing below (EARLIER) and above
(LATER) the median of MENA (Table 3). From 7.9 to
12.4 years, BW, H, and BMI rose significantly, more in
EARLIER than LATER MENA subgroup. The differences
in these anthropometric variables culminated at 12.4 years
of age. They remained statistically significant at 16.4 years
for both BW and BMI, but not for H. At 20.4 years, there
was still a trend for greater BW and BMI in the EARLIER
than in the LATER subgroup (Table 3). From 7.9 to
20.4 years, FN aBMD was constantly greater in the
EARLIER than LATER subgroup. The difference was the
greatest (+14.1%) at 12.4 years, then declined but remained
statistically significant at 20.4 years (+4.8%).
The differences in BW, H, and BMI gains from birth to
1 year and from 1.0 to 7.9 years up to 20.4 years between
the EARLIER and LATER subgroups are presented in
Table 4. These differences corroborate the absolute values
indicating that the pubertal timing influence is expressed on
the gains from 1.0 to 7.4 years on, but not from birth to
1.0 year (Table 4).
Figure 2 illustrates the gains in BMI as expressed in Z-
score from 1.0 to 7.9 years on, in EARLIER as compared to
LATER subgroup. Under the histogram, the distribution of
Table 2 Regressions between Z-scores of body mass index (BMI)
and menarcheal age (A) and between delta Z-scores of BMI and
menarcheal age (B)
N β P 95% CI for R2
Lower Upper
A)
Age (year/s)
Birth 115 −0.070 0.468 −0.259 0.120 0.01
1 96 −0.026 0.804 −0.237 0.184 0.01
7.9 124 −0.336 0.000 −0.505 −0.167 0.11
8.9 123 −0.337 0.000 −0.506 −0.169 0.11
10.0 114 −0.341 0.000 −0.515 −0.166 0.12
12.4 105 −0.455 0.000 −0.644 −0.265 0.18
16.4 113 −0.327 0.001 −0.510 −0.137 0.10
(0.001)a
20.4 124 −0.208 0.020 −0.383 −0.033 0.04
(0.018)a
B)
Delta age (years)
Birth to 1 96 −0.048 0.734 −0.328 0.232 0.01
1 to 7.9 96 −0.245 0.058 −0.499 0.009 0.04
1 to 8.9 96 −0.260 0.050 −0.519 0.000 0.04
1 to 10.0 92 −0.356 0.010 −0.624 −0.088 0.07
1 to 12.4 88 −0.417 0.006 −0.710 −0.123 0.08
1 to 16.4 92 −0.199 0.268 −0.553 0.156 0.01
(0.089)a
1 to 20.4 96 −0.167 0.243 −0.448 0.115 0.02
(0.076)a
CI confidence interval
a After adjustment for smoking and contraceptive pill use
Table 1 Anthropometric and femoral neck aBMD data from birth to
20.4 years in healthy girls
Age (year/s) Weight Height BMI FN aBMD
kg cm kg/cm2 mg/cm2
Birth 3.2±0.4 49.3±2.1 13.0±1.2 NA
n=115
1 9.2±0.9 73.9±3.4 16.9±1.4 NA
n=96
7.9±0.5 26.5±4.1 127.7±5.9 16.2±1.8 634±74
n=124
8.9±0.5 29.8±4.9 132.7±6.1 16.9±2.1 647±75
n=123
10.0±0.5 33.2±5.7 138.8±6.7 17.1±2.1 675±78
n=114
12.4±0.5 44.5±8.1 153.8±7.9 18.7±2.5 751±103
n=106
16.4±0.5 56.8±7.9 164.0±6.2 21.1±2.7 867±111
n=113
20.4±0.6 60.0±9.2 165.0±6.0 22.1±3.4 858±108
n=124
All values are mean±SD. The percent of girls having experienced
their first menstruations was: 0, 1.8, and 25.5% at the age of 8.9, 10.0,
and 12.4 years, respectively. All participants were menstruating at the
visit when their mean age was 16.4.±0.5 year
BMI body mass index, FN Femoral neck, aBMD areal bone mineral
density, NA not available
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the pubertal stages from P1 to P5 documents the difference
in the age-related progression of sexual maturation between
the two MENA subgroups.
Discussion
The recently published report from Javaid et al. [30]
showed that change in BMI during childhood, from 1 to
12 years, was inversely associated with hip fracture risk in
later life. As potential explanations, the authors suggested
either a direct effect of low fat mass on bone mineralization
or altered timing of pubertal maturation [30]. Our study
carried out in a cohort of healthy females whose BMI
remained within the normal range complements this report
by demonstrating that femoral neck aBMD measured by the
end of skeletal development is also linked to gain in BMI
during a very similar time interval, precisely from 1 to
12.4 years. Furthermore, our study documents that BMI
gain during this time frame is inversely correlated with
pubertal timing as prospectively assessed by recording the
age of menarche. We previously reported that in healthy
adult females, a relatively later menarcheal age by 1.9 year
is associated with a deficit in FN aBMD by nearly 0.4 T-
score [12]. Taking into account that FN aBMD tracks from
early to late adulthood [15, 16], our observation should
pertain to the risk of hip fracture in relation with childhood
growth [30]. In the study by Javaid et al., BW and BMI
measured at birth and 1 year of age were not related to hip
fracture [30]. In the same way, our analysis did not reveal
any relationship between these two anthropometric varia-
bles when measured either at birth or at 1 yr of age and the
pubertal timing recorded several years later.
The inverse association between gain in BW or BMI
during childhood and menarcheal age may be interpreted as
a direct effect of fat mass on the neuroendocrine system that
triggers the timing of pubertal maturation [37]. Forty years
ago, Frisch and Revelle [38] put forward the “critical
weight” hypothesis suggesting that a minimum weight
(48 kg) or body fat (22%) should be attained to trigger the
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Fig. 1 Femoral neck aBMD, cortical thickness, and trabecular bone
density of distal tibia measured at peak bone mass: relation with
menarcheal age and change in BMI during childhood. The six linear
regressions were calculated with the data prospectively recorded in
124 healthy girls. The regression equations are indicated above each
plot, with the corresponding correlation coefficient and the statistical
P values. The slopes of the three bone variables (Y) are negatively and
positively related to menarcheal age (upper plots: a, b, c) and change
in BMI from 1.0 to 12.4 years (lower plots: d, e, f), respectively. See
text for further details
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Table 4 Gains in anthropometric variables from birth to 1 year and from 1 year of age in healthy girls segregated by menarcheal age
Age (year/s) Weight (kg) P Height (cm) P BMI (kg/cm2) P
Earlier Later Earlier Later Earlier Later
From birth to 1 6.0±0.8 6.1±1.0 0.506 24.7±2.6 24.9±3.9 0.810 3.8±1.6 3.9±1.9 0.907
n=47 n=49 n=47 n=49 n=47 n=49
1 to 7.9 18.4±3.9 15.9±3.4 0.001 55.2±5.3 52.2±5.7 0.009 −0.2±2.0 1.2±1.9 0.013
n=48 n=49 n=47 n=49 n=47 n=49
1 to 8.9 22.1±4.8 18.9±4.0 0.001 60.7±5.4 56.9±5.9 0.001 0.5±2.4 −0.6±2.2 0.023
n=47 n=49 n=47 n=49 n=47 n=49
1 to 10.0 26.3±5.4 21.8±4.9 0.001 67.8±6.0 62.5±6.3 0.001 1.0±2.2 −0.4±2.4 0.005
n=47 n=46 n=46 n=46 n=46 n=46
1 to 12.4 39.2±6.2 32.0±7.7 0.001 83.7±5.6 76.0±8.7 0.001 2.8±2.4 1.0±2.9 0.002
n=45 n=45 n=44 n=45 n=44 n=45
1 to 16.4 50.2±7.7 45.4±7.4 0.002 91.0±4.9 89.6±6.6 0.231 5.1±2.8 3.5±3.1 0.009
n=45 n=47 n=45 n=47 n=45 n=47
1 to 20.4 53.0±9.1 50.0±10.1 0.136 91.0±5.3 91.3±6.6 0.842 6.1±3.7 4.7±3.8 0.067
n=47 n=49 n=47 n=49 n=47 n=49
All values are mean±SD
BMI body mass index
Table 3 Anthropometric and femoral neck aBMD data from birth to 20.4 years in healthy girls segregated by the median of menarcheal age
Weight (kg) P Standing height (cm) P Body mass index
(kg/cm2)
P FN aBMD (mg/cm2) P
Age
(year/s)
Earlier Later Earlier Later Earlier Later Earlier Later
Birth 3.2±
0.4
3.2±
0.4
0.995 49.4±
2.2
49.2±
1.9
0.680 13.0±
1.2
13.1±
1.3
0.706 NA NA
n=47 n=49 n=47 n=49 n=57 n=58
1 9.1±
0.9
9.3±
1.0
0.408 73.9±
3.2
74.0±
3.6
0.819 16.7±
1.1
17.0±
1.6
0.317 NA NA
n=48 n=49 n=47 n=49 n=47 n=49
7.9±0.5 27.8±
4.2
25.1±
3.5
0.0002 129.1±
5.7
126.3±
5.7
0.006 16.6±
1.9
15.7±
1.6
0.003 640±71 628±77 0.364
n=62 n=62 n=62 n=62 n=62 n=62 n=62 n=62
8.9±0.5 31.6±
5.0
28.1±
4.0
0.0001 134.5±
5.8
130.9±
5.9
0.0001 17.4±
2.2
16.4±
1.8
0.005 658±72 636±77 0.104
n=61 n=62 n=61 n=62 n=61 n=62 n=61 n=62
10.0±0.5 35.4±
5.6
30.9±
4.9
0.0001 141.5±
6.3
136.1±
5.9
0.0001 17.6±
2.1
16.6±
2.0
0.009 689±72 661±81 0.061
n=58 n=56 n=58 n=56 n=58 n=56 n=58 n=56
12.4±0.5 48.6±
6.4
40.2±
7.4
0.0001 157.8±
6.0
149.7±
7.7
0.0001 19.5±
2.2
17.8±
2.5
0.0004 799±84 700±97 0.001
n=54 n=52 n=54 n=52 n=54 n=52 n=54 n=52
16.4±0.5 58.8±
7.4
54.8±
8.0
0.007 164.2±
6.1
163.8±
6.3
0.751 21.8±
2.6
20.4±
2.8
0.005 893±94 841±122 0.014
n=57 n=56 n=57 n=56 n=57 n=56 n=57 n=56
20.4±0.6 61.4±
8.7
58.5±
9.6
0.085 164.7±
6.1
165.1±
6.3
0.703 22.7±
3.3
21.5±
3.4
0.051 878±97 838±116 0.042
n=62 n=62 n=62 n=62 n=62 n=62 n=62 n=62
All values are mean±SD. The percent of girls having experienced their first menstruations was: 0, 1.8, and 25.5% at the age of 8.9, 10.0, and
12.4 years, respectively. All were menstruating at the visit when their mean age was 16.4±0.5 year
BMI body mass index, FN Femoral neck, aBMD areal bone mineral density NA not available
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complex series of events leading to the development of
secondary sexual features. More recently, some but not all
epidemiologic studies from the United States of America [39]
indicated that the secular trend of earlier puberty in girls would
coincide with the progressing prevalence of overweight and
obesity in children [40, 41]. Nevertheless, when this
association was found, the question remained whether earlier
pubertal timing was the result or cause of higher body fat
[42]. Among putative nutrition or fat mass-related mediators,
leptin was specially taken into account. From the analysis of
experimental and clinical evidence, it emerges that leptin
could not be considered as a critical factor [43] that would
determine the wide interindividual variability in pubertal
timing, as repeatedly observed in a large number of healthy
adolescent populations [37, 44], as well as in our cohort with
menarcheal age ranging from 10.2 to 16.0 years. Leptin
should rather be considered as playing a permissive role in
the triggering of the pubertal maturation process [43].
The secular trend in earlier puberty was also observed in
a very large longitudinal multi-cohort study from Denmark
with annual measurements of BW and H in 156,835 school
children born from 1930 to 1969 [45, 46]. However, this
trend was recorded irrespective of the BMI level as
assessed at 7 years of age [45, 46]. Thus, there is no
evidence that fat mass would be an essential physiological
factor causally implicated in the marked variability of
pubertal maturation onset, as worldwide monitored in
healthy children.
In our study, the difference in BMI gain between healthy,
non-obese girls who will experience their first menses
relatively earlier (12.1 years) and later (14.0 years), was
already significant from 1.0 to 8.9 years of age. In absolute
terms at 8.9 years of age, BW was 31.6±5.0 and 28.1±
4.0 kg in the earlier and later groups, respectively. The
corresponding BMI values were 17.4±2.2 and 16.4±
1.8 kg/m2 in the earlier and later subgroup, respectively.
In a previous UK study in healthy girls of similar age (8.6±
0.2 year), BW (29.5±5.7 kg), and H (1.31±0.05 m), with
BMI of 16.9 kg/m2, fat mass was estimated from total body
water measurement by deuterium dilution [47]. Using this
validated method for measuring children body composition
[48], fat mass amounted to 8.0±3.7 kg corresponding to
27% of BW [47]. In our study, the increased BW from 1.0
to 8.9 years of age was 22.1 and 18.9 kg in earlier and later
maturers, respectively. Assuming the same adiposity per-
centage as that estimated by Wells and Cole [47], the
corresponding difference in accumulated fat mass before
the onset of pubertal maturation would be 0.864 kg (27% of
3.2 kg). It is difficult to conceive that less than 1.0 kg of
accumulated fat tissue from 1.0 to 8.9 years of age would
so markedly delay the timing of puberty by nearly 2 years.
For quantitative comparison, the secular trend of earlier
pubertal timing in two nationally representative surveys of
US girls studied 25 years apart, showed that menarcheal
age declined from 12.75 to 12.54 years (12.80 to
12.60 years for white adolescents), corresponding to a
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8 / 37 
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15 / 4 
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0 / 0 
Pubertal Stage (%) at: 7.9 8.9 10.0 12.4 16.4 20.4 yr 
0.016 0.027 0.005 0.003 0.018 0.065 P = 
Fig. 2 Changes in BMI from 1.0 to 20.4 years in healthy subjects
segregated by the median of menarcheal age. The diagram illustrates
that the change in BMI Z-score from 1.0 year of age on between
subjects with menarcheal age below (EARLIER) and above (LATER)
the median is statistically significant at 7.9 and 8.9 years, an age at
which all girls were still prepubertal (Tanner stage P1) as indicated
below the diagram. The difference culminates at 12.4 years, and then
declines afterwards. Note that the progression of BMI from birth to
1.0 year of age was very similar in the EARLIER (from 13.0 to
16.7 kg/m2) and LATER (from 13.1 to 17.0 kg/m2) subgroups (see
Table 3). The number of subjects for each age is presented in Table 3.
See text for further details. P values between EARLIER and LATER
group at each age are indicated above the diagram
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decrease of two and a half months [49]. Between the two
surveys, body weight measured in 10-year-old girls
increased from 35.16 to 37.91 kg and BMI from 17.54 to
18.43 kg/m2 [49]. Therefore, for differences in BW and
BMI similar to those we recorded in our 8.9-year-old girls
between earlier and later maturers, the secular trend for
younger menarcheal age [49] was about ten times less than
in our study, i.e., 2.5 vs. 22.8 months.
Based on accumulating contradictory evidence as
reviewed by Wang [50], several previous reports [51–56]
have questioned the “critical weight” hypothesis [38, 57] in
the determination of menarche timing. Our study, as
compared to the secular trend in earlier menarcheal age
associated with increased prevalence of overweight and
obesity [49] does not support the hypothesis causally
linking fatness to pubertal timing. It appears more likely
that the direction of causation is opposite, maturational
timing affecting body composition [50].
Alike PBM, pubertal timing is under strong genetic
influence, as documented by several twin and family
studies [58–64]. Taking into account this strong influence
of genetics on pubertal timing, the slight increase in BMI
observed in non-obese healthy girls with relatively earlier
menarcheal age could correspond to a secondary phenom-
enon and not to a causal determinant that would be
mediated by some putative adipocyte-secreted factors
responsible for activating the complex process of pubertal
maturation. Therefore, there is no scientific argument to
hamper considering pubertal timing as the independent
variable that would predict BW and/or BMI, rather than the
reverse.
The inverse relationship between the timing of puberty
and bone mineral mass in adulthood has been often
tentatively explained by a difference in estrogen exposure
from prepuberty to PBM attainment. However in a recent
analysis, we reported [13] that the difference in bone
mineral mass between healthy girls experiencing relatively
earlier (12.1±0.7 year) vs. later (14.0±0.7 year) menarche
was already present at 8.9 years of age, when all subjects
were at Tanner stage P1, as assessed by direct examination
by a pediatrician–endocrinologist. Moreover, from that
prepubertal stage up to 20.4 years, aBMD gains at all
skeletal sites examined were similar in earlier and later
menarcheal age subgroups [13]. These results do not
sustain the notion that difference in estrogen exposure from
prepuberty to maturity would explain how pubertal timing
could influence PBM and thereby subsequent risk of
osteoporosis in later life.
Interestingly enough, the difference in PBM between
African– and European–Americans [65] could not be
attributed to faster gain in bone mineral mass during puberty
[66]. This racial difference emerges by early childhood [67],
although it is not observed in infants 1–18 months of age
[68]. The greater velocity of bone accrual in black than white
Americans during childhood, but not during pubertal
maturation, could well be related to racial difference in
pubertal timing [66]. Such a relation would be compatible
with the postulated concept linking pubertal timing and PBM
acquisition by a common genetic programming [14].
In conclusion, in healthy girls, gain in BMI during
childhood is associated with pubertal timing as prospec-
tively assessed by recording menarcheal age. This reliable
sexual maturation milestone is inversely correlated with
several bone traits measured at peak bone mass, including
femoral neck aBMD, cortical thickness, and volumetric
trabecular density of distal tibia. These data are in
accordance and complement further the reported relation-
ship between childhood BMI gain and hip fracture risk in
later life [30]. They strongly suggest that BMI gain in
children with body weight within the normal range is
influenced by pubertal timing as assessed by menarcheal
age which in turn, has been shown in several postmeno-
pausal women studies to be inversely related to aBMD or
BMC and to increased risk of fragility fractures at several
sites of the skeleton including at the hip level.
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